Jeff Yass’s AtriCure ATRC Stock Holding History

Jeff Yass’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Buy	+65,100	New	+$1.83M	﹤0.01%	6704
2024 Q3	–	Sell	-19,600	Closed	-$446K	–	11928
2024 Q2	$446K	Sell	19,600 -68,600	-78%	-$1.58M	﹤0.01%	8537
2024 Q1	$2.68M	Buy	+88,200	New	+$2.95M	﹤0.01%	4727
2020 Q4	–	Sell	-5,700	Closed	-$227K	–	10985
2020 Q3	$227K	Buy	5,700 +200	+4%	+$8.48K	﹤0.01%	9253
2020 Q2	$247K	Sell	5,500 -77,900	-93%	-$3.39M	﹤0.01%	8678
2020 Q1	$2.8M	Buy	+83,400	New	+$3M	﹤0.01%	3403
2019 Q4	–	Sell	-21,400	Closed	-$534K	–	9682
2019 Q3	$534K	Buy	+21,400	New	+$611K	﹤0.01%	7148
2019 Q1	–	Sell	-9,000	Closed	-$275K	–	8788
2018 Q4	$275K	Buy	+9,000	New	+$280K	﹤0.01%	7157
2017 Q4	–	Sell	-16,500	Closed	-$369K	–	9212
2017 Q3	$369K	Sell	16,500 -800	-5%	-$18.1K	﹤0.01%	7047
2017 Q2	$420K	Sell	17,300 -15,000	-46%	-$319K	﹤0.01%	6963
2017 Q1	$619K	Buy	+32,300	New	+$566K	﹤0.01%	6099

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jeff Yass's ATRC Position: Q2 2026 in Review

Jeff Yass reduced its AtriCure (ATRC) stake by 63% in Q2 2026, selling an estimated $685K and leaving 14,450 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #10384.

Jeff Yass first reported a position in ATRC in Q4 2016 and has held it in 23 quarters since. The position peaked at $2.51M in Q1 2020. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Jeff Yass held 14,450 shares of AtriCure worth $404K as of Q2 2026.
Jeff Yass sold 24,327 AtriCure shares in Q2 2026, an estimated $685K.
AtriCure made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10384 holding.
Jeff Yass first reported a position in AtriCure in Q4 2016 and has held it in 23 quarters since.
Jeff Yass's AtriCure position peaked at $2.51M in Q1 2020.
250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.